Refine
Has Fulltext
- yes (131)
Is part of the Bibliography
- yes (131)
Year of publication
- 2023 (131) (remove)
Document Type
- Doctoral Thesis (130)
- Journal article (1)
Keywords
- Tissue Engineering (6)
- Angststörung (5)
- Thrombozyt (5)
- Biene (4)
- Funktionelle Kernspintomografie (4)
- Maus (4)
- Zellzyklus (4)
- Immunologie (3)
- Makrophage (3)
- Melanom (3)
- Mikroskopie (3)
- Neurodegeneration (3)
- Platelet (3)
- Small RNA (3)
- Zellskelett (3)
- fMRI (3)
- platelets (3)
- ADHD (2)
- Altern (2)
- Alzheimerkrankheit (2)
- Aufmerksamkeit (2)
- Biofabrication (2)
- Biomarker (2)
- Bortezomib (2)
- Brain-derived neurotrophic factor (2)
- CRISPR/Cas-Methode (2)
- CRISPR/Cas9 (2)
- Campylobacter jejuni (2)
- Cement (2)
- Cytoskeleton (2)
- Dünndarm (2)
- Endothel (2)
- Epigenetik (2)
- Expansion Microscopy (2)
- Expositionstherapie (2)
- Fibromyalgie (2)
- Galectine (2)
- Gephyrin (2)
- Graft-versus-host-disease (2)
- Immunsuppression (2)
- Induzierte pluripotente Stammzelle (2)
- Inhibitorische Synapse (2)
- Inhibitory synapse (2)
- Interleukin 6 (2)
- Kernspintomografie (2)
- Kognition (2)
- Krebs <Medizin> (2)
- MMB (2)
- Monarchfalter (2)
- Neurofascin (2)
- Neuroinflammation (2)
- Neurowissenschaften (2)
- Organische Synthese (2)
- Orientierung (2)
- Parkinson-Krankheit (2)
- Peptidsynthese (2)
- Pflanzen (2)
- Regulatorischer T-Lymphozyt (2)
- Ribosom (2)
- SPECT (2)
- Schlaganfall (2)
- Sepsis (2)
- Spinale Muskelatrophie (2)
- Stammzelle (2)
- Transkriptomanalyse (2)
- Transplantat-Wirt-Reaktion (2)
- Zellmigration (2)
- Zement (2)
- bee (2)
- division of labor (2)
- gephyrin (2)
- honeybee (2)
- ischemic stroke (2)
- 18S rRNA (1)
- 3 D bioprinting (1)
- 3D Gewebemodelle (1)
- 3D Printing (1)
- 3D cell culture (1)
- 3D image analysis (1)
- 3D tissue model (1)
- 3D-Druck (1)
- 3D-Zellkultur (1)
- ATR-FTIR (1)
- Actin cytoskeleton-related protein (1)
- Adjuvans (1)
- Adrenocortical Carcinoma (1)
- Affinity probe (1)
- Agoraphobie (1)
- Aktivierungsenergie (1)
- Akzeptanz (1)
- Akzeptanz- und Commitment Therapie (1)
- Allogenic hematopoietic stem cell transplantation (1)
- Alternative zum Tierversuch (1)
- Alzheimer's Dementia (1)
- Alzheimer's disease (1)
- AmGr1, AmGr2, AmGr3 (1)
- Amygdala (1)
- Angst (1)
- Angst als Zustand (1)
- Angsterkrankung (1)
- Animal model (1)
- Anxiety disorder (1)
- Anxiety disorders (1)
- Apis mellifera (1)
- Apoptosis (1)
- Arteriosklerose (1)
- Arzneimitteldesign (1)
- Aspergillus fumigatus (1)
- Atemwege (1)
- Atemwegsschleimhaut (1)
- Atherogenese (1)
- Atherosclerosis (1)
- Atherosklerose (1)
- Attentional bias (1)
- Aufmerksamkeitsdefizit-Syndrom (1)
- Aufmerksamkeitsprozesse (1)
- Aurora-A (1)
- Aurora-A-MYCN-Komplex (1)
- Autoantikörper (1)
- Autoinhibition (1)
- Awareness (1)
- B-MYB (1)
- B-Zell-Lymphom (1)
- BDNF stimulation (1)
- BOLD signal (1)
- BRET (1)
- Bacterial infection (1)
- Baghdadite (1)
- Bakterielle Infektion (1)
- Bandwürmer (1)
- Bauchspeicheldrüse (1)
- Bauchspeicheldrüsenkrebs (1)
- Bed nucleus of stria terminalis (1)
- Benzimidazolderivate (1)
- Bestärkendes Lernen <Künstliche Intelligenz> (1)
- Bildgebendes Verfahren (1)
- Bimolekulare Lipidschicht (1)
- Bindegewebe (1)
- Bioinformatics (1)
- Biologie (1)
- Biomechanics (1)
- Biomechanik (1)
- Bioreactor (1)
- Blick (1)
- Blood nerve barrier (1)
- Blut-Hirn-Schranke (1)
- Bone-replacement (1)
- Brownsche Bewegung (1)
- CA3 (1)
- CD28 Superagonist (1)
- CIDP (1)
- CMV (1)
- CVT (1)
- CXCR4 (1)
- CYP24A1 (1)
- CYP7A1 (1)
- Cadherine (1)
- Calcium Phosphate (1)
- Calciumphosphat (1)
- Cell adhesion (1)
- Cell cycle (1)
- Characterization (1)
- Chemokin CXCL12 (1)
- Chemotherapie (1)
- Children (1)
- Cholesterinstoffwechsel (1)
- Chromatin (1)
- Chronische Niereninsuffizienz (1)
- Circadian (1)
- Clostridium difficile (1)
- Comorbidity (1)
- Contactin-1 (1)
- Corpus amygdaloideum (1)
- Correlative microscopy (1)
- Coxiella burnetii (1)
- Crosstalk (1)
- Cytomegalie-Virus (1)
- Cytotoxic T cell (1)
- DHX30 (1)
- DNS-Reparatur (1)
- DNS-Schädigung (1)
- Danaus plexippus (1)
- Deep-sequencing (1)
- Dendritische Zelle (1)
- Dendritische Zellen (1)
- Dephosphorylierung (1)
- Depression (1)
- Diabetic painful neuropathy (1)
- Diagnostik (1)
- Diffusion coefficient (1)
- Dorsal root ganglion (1)
- Dual-setting (1)
- Dynamics of ribosome assembly (1)
- ER dynamics in axon terminals (1)
- Echinococcus (1)
- Echokardiographie (1)
- Echtzeit (1)
- Ecological Momentary Assessment (1)
- Einfühlung (1)
- Einfühlung <Motiv> (1)
- Einsamkeit (1)
- Einzelzellanalyse (1)
- Elektrophysiologie (1)
- Emotionsregulation (1)
- Endocytose (1)
- Endocytosis (1)
- Endophänotypen (1)
- Endoplasmatisches Retikulum (1)
- Endosomes (1)
- Endothelium (1)
- Endozytose (1)
- Enterobacteriaceae (1)
- Entzündung (1)
- Erregbarkeit (1)
- Excitatory/inhibitory imbalance (1)
- Exposure treatment (1)
- Expression (1)
- Extinktion (1)
- Extrazellulärmatrix (1)
- Exzitatorische Synapse (1)
- FAT10ylation (1)
- FOXP2 (1)
- FRET (1)
- Fabry disease (1)
- Fabry-Krankheit (1)
- Fear generalization (1)
- Fettleber (1)
- Fettsäurestoffwechsel (1)
- Fibromyalgia syndrome (1)
- Fibromyalgiesyndrom (1)
- Flavonoids (1)
- FluidFM (1)
- Fluorescence Microscopy (1)
- Fluorescence microscopy (1)
- Fluorescent probes (1)
- Fluoreszenz-Resonanz-Energie-Transfer (1)
- Fluoreszenzmikroskopie (1)
- Fluoreszenzsonde (1)
- Forkhead Transcription Factors (1)
- Forkhead-Box-Proteine (1)
- FoxO transcription factors (1)
- Freies Molekül (1)
- Fructosebisphosphat-Aldolase (1)
- Frühe Gene (1)
- Fuchsbandwurm (1)
- Furchtentwicklung (1)
- Furchtgeneralisierung (1)
- Furchtkonditionierung (1)
- Fusobacterium nucleatum (1)
- Förster Resonanz Energie Transfer (1)
- G-Protein gekoppelter Rezeptor (1)
- G2/M genes (1)
- GAD1 (1)
- GC1 cells (1)
- GLA KO mouse model (1)
- GPCR (1)
- GRM8 (1)
- Galectin 1 (1)
- Ganzkörperbestrahlung (1)
- Gas chromatography (1)
- Gaschromatographie (1)
- Gehirn (1)
- Genetic etiology (1)
- Genexpression (1)
- Genomics (1)
- Genotyping (1)
- Genregulation (1)
- Germinative Zellen (1)
- Gewebemodell (1)
- Gewebemodelle (1)
- Glioblastoma (1)
- Glucocorticoids (1)
- Glycocalyx (1)
- Glykane (1)
- Glykobiologie (1)
- Glykokalyx (1)
- Graft-versus-host disease (GvHD) (1)
- Graft-versus-leukemia (1)
- Gram-positive (1)
- Granulozyten (1)
- Guanine nucleotide exchange factor (GEF) (1)
- GvL (1)
- Gvhd (1)
- HASH (1)
- HCMV (1)
- HPLC-MS (1)
- Habituationstraining (1)
- Hautleitfähigkeit (1)
- Hautmodell (1)
- Helicobacter pylori (1)
- Herpes (1)
- Herz (1)
- Herzfrequenz (1)
- Herzfunktion (1)
- Herzinfarkt (1)
- Herzinsuffizienz (1)
- Herzmuskel (1)
- Heterogenität von Mikroorganismen (1)
- Hfq (1)
- Hippocampus (1)
- Homing (1)
- Humanparasitologie (1)
- Hybrid-Molecules (1)
- Hyperactivity (1)
- Hypothalamus (1)
- IE3 (1)
- IL-2 (1)
- IP6 (1)
- IVIG (1)
- Ibrutinib (1)
- Image Quality (1)
- Immune Checkpoint Therapy (1)
- Immune System (1)
- Immune cell assays (1)
- Immunkardiologie (1)
- Immunocardiology (1)
- Immunology (1)
- Immunotherapy (1)
- Immunsystem (1)
- Immuntherapie (1)
- Immunzellassays (1)
- Impulsivität (1)
- In-vitro-Kultur (1)
- Induced pluripotent stem cells (1)
- Infection models (1)
- Infectious diseases (1)
- Infektiologie (1)
- Infektionsmodell (1)
- Infektionsstudien (1)
- Inhibitor (1)
- Inhibitory-postsynapse (1)
- Injectability (1)
- Insekten (1)
- Integrin (1)
- Interaktion (1)
- Interleukin 2 (1)
- Internalisierende Störung (1)
- Isolation and Characterization (1)
- K-Ras (1)
- Kardiologie (1)
- Keratinozyt (1)
- Kind (1)
- Kinderpsychiatrie (1)
- Kindesalter (1)
- Knochenersatz (1)
- Knochenmark (1)
- Knochenmarktransplantation (1)
- Knochenmetastase (1)
- Knochenmetastasen (1)
- Kohlenhydrate (1)
- Kolloid (1)
- Komorbidität (1)
- Komplement <Immunologie> (1)
- Komplementsystem (1)
- Koronare Herzkrankheit (1)
- Korrelative Mikroskopie (1)
- Krebsforschung (1)
- Kutikula (1)
- Körperachsen (1)
- Körperliche Leistungsfähigkeit (1)
- Künstliche Ingelligenz (1)
- Ldlr-Knockout (1)
- Lebensmittelchemie (1)
- Leukaemia-inhibitory factor (1)
- Library of Phytochemicals (1)
- Library of plant species (1)
- Lidschlag (1)
- Locomotor activity (1)
- Lungenkrebs (1)
- Lysosome (1)
- MAP-Kinase (1)
- MCMV (1)
- MEK5/ERK5 cascade (1)
- MRT (1)
- MYC (1)
- MYCN (1)
- Macrophages (1)
- Malignant melanoma (1)
- Mantle cell lymphoma (1)
- Maschinelles Lernen (1)
- Massenspektrometrie (1)
- Masspectrometry (1)
- Mausmodell (1)
- Megakaryozyt (1)
- Melt electrowriting (1)
- Metabolic Glycoengineering (1)
- Metastase (1)
- Microscopy (1)
- Microwave Assisted Extraction (1)
- Mikrotubuli (1)
- Mikrotubuli-assoziiertes Protein (MAP) (1)
- Mitose (1)
- Modellierung (1)
- Moderator (1)
- Modification (1)
- ModulationTregs (1)
- Molekulare Bildgebung (1)
- Monoklonale Gammopathie (1)
- Morbus Fabry (1)
- Motoneuron (1)
- Motoneuron-Krankheit (1)
- Multi-Unit Aufnahmen (1)
- Multidrugresistant (1)
- Multilayered skin tissue model (1)
- Multiples Myelom (1)
- Myc (1)
- Myeloid-derived suppressor cells (1)
- Myocardial infarction (1)
- Myokardiale Deformation (1)
- Myosin IIA (1)
- NA (1)
- NAFLD (1)
- NEDMIAL (1)
- NFAT (1)
- NFATc1 (1)
- NFATc3 (1)
- NMR (1)
- NaV1.9 (1)
- Narrow escape problem (1)
- Natriumkanal (1)
- Nature-Insipired Synthesis (1)
- Naturstoff (1)
- Nebenniere (1)
- Nebennierenrindenkarzinom (1)
- Nebennierentumor (1)
- Nervenstimulation (1)
- Neurodevelopmental diseases (1)
- Neuroepigenomics (1)
- Neuromodulation (1)
- Neuropathic pain (1)
- Neuropathie (1)
- Neuroprotection (1)
- Neuroscience (1)
- Neutrophils (1)
- Nicht-kleinzelliges Bronchialkarzinom (NSCLC) (1)
- Nociceptor (1)
- Non-coding RNA (1)
- Noonan-Syndrom (1)
- Olfaktorik (1)
- Onchocerca volvulus (1)
- Onchozerkose (1)
- Oncogenes (1)
- Oncostatin M (1)
- Optogenetics (1)
- Optogenetik (1)
- Osmr-Knockout (1)
- Oxytocin (1)
- PAR-CLIP (1)
- PD-L1 (1)
- PEG (1)
- PER (1)
- PGE2 (1)
- PROTAC (1)
- PTH1R (1)
- Panikstörung (1)
- Pankreas (1)
- Paranodopathie (1)
- Parasitology (1)
- Parkinson's disease (1)
- Pathogenesis (1)
- Pathogenität (1)
- Pathophysiologie (1)
- Peptide (1)
- Peripheral eosinophils (1)
- Peripheres Nervensystem (1)
- Pesticide (1)
- Peyersche Plaques (1)
- Phosphoglykolatphosphatase (1)
- Phospholipide (1)
- Phylogenie (1)
- Phylogeny (1)
- Plant extracts (1)
- Plants (1)
- Plasmozytom (1)
- Plastin 3 (1)
- Platelets (1)
- Platy (1)
- Polymere (1)
- Polymers (1)
- Polyneuropathie (1)
- Polysaccharide (1)
- Prognose (1)
- Programmed Cell Death 1 (1)
- Programmed Cell Death Ligand 1 (1)
- Proliferation (1)
- Promotor (1)
- Prosoziales Verhalten (1)
- Prostaglandin E2 (1)
- Proteasom (1)
- Proteasome (1)
- Protein-Protein-Wechselwirkung (1)
- Proteintyrosinphosphatase (1)
- Proteolysis-Targeting-Chimera (1)
- Pseudouridin (1)
- RAMP (1)
- RIL-seq (1)
- RIM1α (1)
- RNA helicase (1)
- RNA metabolism (1)
- RNA modifications (1)
- RNA-Protein Interaktom (1)
- RNA-RNA interactions (1)
- RNA-Sequenzierung (1)
- RNA-bindendes Protein (1)
- RNA-protein interactome (1)
- RNS-Bindungsproteine (1)
- RNS-Viren (1)
- Random Forest (1)
- Random-walk simulations (1)
- Ranvier-Schnürring (1)
- Rbm8a (1)
- Reaktive Sauerstoffspezies (1)
- Regenerative Medizin (1)
- Regulation (1)
- Regulatory T Cells (1)
- Rekonsolidierung (1)
- Reproducibility challenges (1)
- Reprogrammming (1)
- Rezeptor (1)
- Rezeptor-Tyrosinkinasen (1)
- Rheology (1)
- Rho GTPasw (1)
- Rho-Kinasen (1)
- RhoA (1)
- Rodents (1)
- SARS-CoV-2 (1)
- SET7 (1)
- SPECT/CT (1)
- STAAB study (1)
- STAAB-Studie (1)
- SUMOylation (1)
- Salmonella (1)
- Satellite glial cell (1)
- Scherstress (1)
- Schlaf (1)
- Schmerz (1)
- Schmerzforschung (1)
- Schmetterlinge (1)
- Schwertkärpfling (1)
- Schädel-Hirn-Trauma (1)
- Sehen (1)
- Sekundärkrankheit (1)
- Sequence-Structure (1)
- Sequenzdaten (1)
- Serotonin (1)
- Setting Control (1)
- Shear Stress (1)
- Silica precursor (1)
- Single-cell RNA Sequencing (1)
- Single-cell RNA-sequencing (1)
- Sinusthrombose (1)
- Skin Tissue Engineering (1)
- Sleep (1)
- Social Buffering (1)
- Social Distancing (1)
- Sol-gel (1)
- Solid-phase peptide synthesis (1)
- Sozialer Kontakt (1)
- Specialized pro resolving mediators (1)
- Speckle Tracking (1)
- Spinal Muscular Atrophy (1)
- Spinalganglion (1)
- Spo0A (1)
- Sporenbildung (1)
- Sporulation (1)
- Spred-Proteine (1)
- Stammzelltransplantation (1)
- Steroide (1)
- Steroidhormon (1)
- Stimulationsversuche (1)
- Stroke Unit (1)
- Strumpellin (1)
- Super-Resolution Microscopy (1)
- Synaptische Transmission (1)
- Synaptische Vesikel (1)
- Synthese (1)
- Synthesis (1)
- T Helper Cell (1)
- T Lymphocyte (1)
- T-Lymphozyt (1)
- T-Zellmigration (1)
- TAC (1)
- TLR3 (1)
- TRRAP (1)
- Tagesrhythmus (1)
- Targeted therapy (1)
- Temporal predictability (1)
- Theory of Mind (1)
- Therapie (1)
- Therapieresistenz (1)
- Thigmotaxis (1)
- Thrombose (1)
- Thrombosis (1)
- Thrombozytenfunktion (1)
- Tiermodell (1)
- Tissue staining (1)
- Transkription <Genetik> (1)
- Transplantatabstoßung (1)
- Transposon (1)
- Transthorakale Echokardiographie (1)
- Traumatic neuropathy (1)
- Treg (1)
- Trem2 (1)
- TruD (1)
- Trypanosoma (1)
- Trypanosoma brucei (1)
- Trypanosomiasis (1)
- Tumor (1)
- UBA6 (1)
- UBE2Z (1)
- Ubiquitylation (1)
- Ultraschall (1)
- VE-Cadherin (1)
- VE-PTP (1)
- VLA-1 (1)
- Validierungsstudie (1)
- Vasopressin (1)
- Vernetzung <Chemie> (1)
- Verwundbarkeit (1)
- Vibrationstraining (1)
- Virus infection (1)
- Visuelle Orientierung (1)
- Visuelle Wahrnehmung (1)
- Vitamin D (1)
- Vitamin D-Rezeptor (1)
- Vitamin D3 (1)
- Vorhersage (1)
- WASH complex (1)
- Wahrnehmung (1)
- Waiting Impulsivity (1)
- Web services (1)
- Wirkstoffdesign (1)
- Wnt-Signalweg (1)
- Wnt-pathway (1)
- Xiphophorus (1)
- YAP (1)
- Zebrafish (1)
- Zelldifferenzierung (1)
- Zellkern (1)
- Zellteilung (Zytokinese) (1)
- acceptance-based strategies (1)
- active zone (1)
- acute brain slices (1)
- adrenal incidentaloma (1)
- adrenocortical adenoma (1)
- adrenocortical carcinoma (1)
- aging (1)
- allogenic stem cell transplantation (1)
- allografts (1)
- alpha-IIb beta-3 (1)
- amygdala (1)
- anaerobe (1)
- anterior insula (1)
- anxiety disorders (1)
- artificial human skin (1)
- attention (1)
- bee-lining (1)
- benzimidazole (1)
- beta cell (1)
- beta-Catenin (1)
- biofabrication (1)
- bioink (1)
- biology (1)
- bitter taste (1)
- blood brain barrier (1)
- body axis (1)
- bone marrow (1)
- bone metastases (1)
- brain (1)
- calcium activity (1)
- cancer (1)
- cell migration (1)
- central complex (1)
- chromatin accessibility (1)
- cine loop (1)
- closing of chromatin (1)
- cognitive decline (1)
- collybistin (1)
- conformational activation (1)
- dendritic cells (1)
- developmental differentiation (1)
- dexamethasone suppression test (1)
- diagnostic accuracy (1)
- diet (1)
- differential RNA-seq (1)
- drift-diffusion model (1)
- early detection (1)
- echocardiography (1)
- electron tomography (1)
- electrophysiology (1)
- endosomal trafficking (1)
- enhancers (1)
- epigenetics (1)
- exposure therapy (1)
- expression (1)
- extinction (1)
- extracellular matrix (1)
- eye contact (1)
- fMRI time series (1)
- feasibility (1)
- feral bees (1)
- fluorescence resonance energy transfer (FRET) (1)
- fmri activity (1)
- forager (1)
- forest landscape (1)
- foxtapeworm (1)
- functional neuroimaging (1)
- functional resting-state connectivity (1)
- funktionelle Kernspintomographie (1)
- funktionelle Magnetresonanztomographie (1)
- funktionelle Resting-State Konnektivität (1)
- genetic modification (1)
- genetic screen (1)
- gp130 (1)
- haloacid dehalogenase phosphatase (1)
- high-pressure freezing/freeze substitution (1)
- honey bee density (1)
- hyaluronic acid (1)
- hydrogel (1)
- iPSCs (1)
- immediate early genes (1)
- immune evasion (1)
- inferior frontal gyrus (1)
- inflammatory pain (1)
- inhibitory postsynapse (1)
- innate immunity (1)
- ischämischer Schlaganfall (1)
- juvenile hormone (1)
- kinase (1)
- late enhancement (1)
- late gadolinium-enhancement (1)
- light sheet fluorescence microscopy (1)
- luciferase assay (1)
- lytic infection (1)
- macrophages (1)
- magnetic resonance imaging (1)
- malnourishment (1)
- mean first passage time (1)
- mesenchymal stem cells (1)
- metabolite repair (1)
- miRNA (1)
- miRNA target (1)
- miRNS (1)
- mild cognitive impairment (1)
- molecular mechanism (1)
- monarch butterfly (1)
- monocyte-derived dendritic cells (1)
- monozytenderivierte dendritische Zellen (1)
- mossy fiber synapse (1)
- multi-pinhole collimation (1)
- multi-unit recording (1)
- myeloablation (1)
- myocardial deformation (1)
- neuroinflammation (1)
- neurologin-2 (1)
- neuronal excitability (1)
- neuropaticher Schmerz (1)
- nurse bee (1)
- olfaction (1)
- opening of chromatin (1)
- optical clearing (1)
- orientation (1)
- p53 (1)
- pain regulation (1)
- pancreas (1)
- pancreatic cancer (1)
- pancreatic differentiation (1)
- perception (1)
- performance evaluation (1)
- peripheral nervous system (1)
- pharmacology (1)
- phosphoglycolate phosphatase (1)
- platelet (1)
- point-of-care (1)
- post-transcriptional regulation (1)
- potenzielles therapeutisches Target (1)
- presynaptic (1)
- quiescence (1)
- real-time imaging (1)
- reciprocity (1)
- regenerative medicine (1)
- regulatory RNA (1)
- reporter screen (1)
- responsiveness (1)
- reversible oxidation (1)
- ribosome biogenesis (1)
- self-targeting CRISPR-Cas (1)
- sigma factor (1)
- single particle tracking (1)
- single-cell RNA sequencing (1)
- single-molecule localization microscopy (1)
- skin equivalent (1)
- small RNA expression (1)
- small-animal SPECT (1)
- social understanding (1)
- specific phobia (1)
- speckle tracking (1)
- spezifische Phobie (1)
- spider phobia (1)
- spiral trajectory (1)
- spontaneous blinks (1)
- strain (1)
- strain rate (1)
- sugar perception (fructose, sucrose) (1)
- sugar receptor (1)
- super-resolution microscopy (1)
- systemic inflammation (1)
- tapeworm (1)
- temporo-parietal junction (1)
- thrombo-inflammation (1)
- thrombopoiesis (1)
- time-correlated single photon counting (TCSPC) (1)
- tissue engineering (1)
- transcription (1)
- transcriptional termination site (1)
- tumor microenvironment (1)
- unklarer Signifikanz (1)
- validation study (1)
- vascular structure (1)
- vasp (1)
- vdr (1)
- ve-cadherin (1)
- viral genome packaging (1)
- viral miRNAs (1)
- vision (1)
- visual cue (1)
- visual perception (1)
- vitamin d (1)
- vitamin d receptor (1)
- waggle dance decoding (1)
- wax (1)
- wild-living honey bees (1)
- xiphophorus (1)
- zentrale Spindel und Mittelkörper (1)
- Überexpression (1)
Institute
- Graduate School of Life Sciences (131) (remove)
Sonstige beteiligte Institutionen
- Helmholtz Institute for RNA-based Infection Research (HIRI) (2)
- Rudolf Virchow Center for Integrative and Translational Bioimaging, University of Würzburg (2)
- Carl-Ludwig-Institut für Physiologie, Universität Leipzig (1)
- Chair of Experimental Biomedicine I (1)
- Evangelisches Studienwerk e.V. (1)
- Fraunhofer Institute for Integrierte Schaltungen (IIS) (1)
- Helmholtz Center for RNA-based Infection Research (1)
- Helmholtz Institute for RNA-based Infection Research (1)
- Helmholtz-Institut für RNA-basierte Infektionsforschung (1)
- IZKF Research Laboratory Dept. Medicine II & Pediatrics (1)
Chronic pain conditions are a major reason for the utilization of the health care system. Inflammatory pain states can persist facilitated by peripheral sensitization of nociceptors. The voltage-gated sodium channel 1.9 (NaV1.9) is an important regulator of neuronal excitability and is involved in inflammation-induced pain hypersensitivity. Recently, oxidized 1-palmitoyl-2-arachidonoyl-sn-glycerol-3-phosphatidylcholine (OxPAPC) was identified as a mediator of acute inflammatory pain and persistent hyperalgesia, suggesting an involvement in proalgesic cascades and peripheral sensitization. Peripheral sensitization implies an increase in neuronal excitability. This thesis aims to characterize spontaneous calcium activity in neuronal compartments as a proxy to investigate neuronal excitability, making use of the computational tool Neural Activity Cubic (NA3). NA3 allows automated calcium activity event detection of signal-close-to-noise calcium activity and evaluation of neuronal activity states. Additionally, the influence of OxPAPC and NaV1.9 on the excitability of murine dorsal root ganglion (DRG) neurons and the effect of OxPAPC on the response of DRG neurons towards other inflammatory mediators (prostaglandin E2, histamine, and bradykinin) is investigated. Using calcium imaging, the presence of spontaneous calcium activity in murine DRG neurons was established. NA3 was used to quantify this spontaneous calcium activity, which revealed decreased activity counts in axons and somata of NaV1.9 knockout (KO) neurons compared to wildtype (WT). Incubation of WT DRG neurons with OxPAPC before calcium imaging did not show altered activity counts compared to controls. OxPAPC incubation also did not modify the response of DRG neurons treated with inflammatory mediators. However, the variance ratio computed by NA3 conclusively allowed to determine neuronal activity states. In conclusion, my findings indicate an important function of NaV1.9 in determining the neuronal excitability of DRG neurons in resting states. OxPAPC exposition does not influence neuronal excitability nor sensitizes neurons for other inflammatory mediators. This evidence reduces the primary mechanism of OxPAPC-induced hyperalgesia to acute effects. Importantly, it was possible to establish an approach for unbiased excitability quantification of DRG neurons by calcium activity event detection and calcium trace variance analysis by NA3. It was possible to show that signal-close-to-noise calcium activity reflects neuronal excitability states.
Die Interaktion des onkogenen Transkriptionsfaktors MYCN mit der Ser/Thr Kinase Aurora-A verhindert
dessen Abbau über das Ubiquitin Proteasomsystem indem die Rekrutierung des SCF FbxW7 Komplexes
verhindert wird. Die Kinase nimmt mit der Bindung an MYCN eine aktive Konformation ein und erhält
somit die Fähigkeit zur Kinaseaktivität ohne die sonst notwendige Phosphorylierung von Thr288 oder
die Anwesenheit eines Aktivators wie TPX2. Da hohe MYCN Konzentrationen Tumore wie
Neuroblastome antreiben, ist die Störung der Komplexbildung mit Aurora-A eine valide Strategie zur
Entwicklung von Chemotherapeutika. Einige Inhibitoren von Aurora-A wie Alisertib (MLN8237) sind in
der Lage, eine Konformationsänderung in der Kinase zu verursachen, die mit der Bindung von MYCN
inkompatibel ist und auf diese Weise den Abbau des Transkriptionsfaktors induziert. Da Aurora-A
wichtige Funktionen in der Mitose übernimmt, könnte eine direkte Adressierung des Komplexes anstelle
einer systemischen Inhibition der Kinase vielversprechender sein.
Ziel des Projektes war die Identifizierung von Molekülen, die selektiv an das Interface des
Aurora-A – MYCN Komplexes binden und weiter optimiert werden können, um einen gezielten Abbau
des Transkriptionsfaktors über einen PROTAC Ansatz zu ermöglichen. Virtuelle Screenings und
molekulardynamische Simulationen wurden durchgeführt, um kommerziell erhältliche Verbindungen zu
identifizieren, welche mit einer Bindetasche des Komplexes interagieren, die nur zustande kommt, wenn
beide Proteine miteinander interagieren. Aus einem ersten Set von zehn potentiellen Liganden wurde
für vier eine selektive Interaktion mit dem Protein – Protein Komplex gegenüber Aurora-A oder MYCN
alleine in STD-NMR Experimenten bestätigt. Zwei der Hits besaßen ein identisches Grundgerüst und
wurden als Ausganspunkt für die Optimierung zu potenteren Liganden genutzt. Das Gerüst wurde
fragmentweise vergrößert und in Richtung besserer in-silico Ergebnisse und Funktionalisierung zur
Anbringung von E3-Ligase-Liganden optimiert. Neun dieser Liganden der zweiten Generation wurden
synthetisiert.
Um quantitative Bindungsdaten zu erhalten, wurde ein kovalent verknüpftes Aurora-A – MYCN
Konstrukt entworfen. Die strukturelle und funktionale Integrität wurde in STD-NMR und BLI
Experimenten mit bekannten Aurora-A Inhibitoren bestätigt, sowie in NMR-basierten ATPase Assays.
Zusätzlich konnte die Kristallstruktur des Konstrukts gelöst und damit die Validität des Designs bestätigt
werden. Quantitative Messungen der synthetisierten Moleküle identifizierten HD19S als Hit mit einer
zehnfach höheren Affinität für das Aurora-A – MYCN Konstrukt im Vergleich zu der Kinase allein.
Zusätzlich wurden in-silico Untersuchungen zu PROTACs der Aurora-A Kinase durchgeführt.
Interaktionen zwischen Aurora-A, der E3-Ligase Cereblon und den Liganden wurden modelliert und für
die Erklärung unterschiedlicher Aktivitäten der eingesetzten PROTACs verwendet. Zudem zeigte das
aktivste PROTAC eine hohe Selektivität für Aurora-A gegenüber Aurora-B, obwohl die verwendete
Erkennungseinheit (Alisertib) an beide Aurora-Proteine bindet. Dieser Umstand konnte durch
energetische Analysen von molekulardynamischen Simulationen der ternären Komplexe erklärt werden.
Optimierungsmöglichkeiten für eine effizientere Degradation von Aurora-A durch die PROTACs wurden
basierend auf modifizierten Erkennungseinheiten und verbesserten Linkern untersucht.
Ein Schlüsselereignis, welches dem prognosebestimmenden Organversagen bei systemi-schen Entzündungsprozessen und Sepsis vorangeht, ist die Entwicklung einer mikrovas-kulären endothelialen Schrankenstörung. Das vaskuläre endotheliale (VE-) Cadherin als mechanischer Stabilisator der Endothelbarriere spielt dabei eine wichtige Rolle. In der Inflammation werden Spaltprodukte von VE-Cadherin (sVE-Cadherin) gebildet. Ge-genstand der vorliegenden Arbeit war die Untersuchung der Hypothese ob diese Spalt-produkte selbst an der Störung der endothelialen Barrierefunktion beteiligt sind.
Es wurde hierfür humanes sVE-Cadherin bestehend aus den extrazellulären Domänen EC1-5 (sVE-CadherinEC1-5) generiert. In Messungen des transendothelialen elektrischen Widerstands (TER), mit Immunfluoreszenzfärbungen und Western Blot Analysen wird gezeigt, dass sVE-Cadherin dosisabhängig die Barriere Integrität in primären humanen dermalen Endothelzellen stört. Dies führt zu einer Reduktion von VE-Cadherin und den assoziierten Proteinen α-, γ- und δ-Catenin und ZO-1, die nach der Applikation von sVE-Cadherin an den Zellgrenzen reduziert sind. Die Interaktion zwischen VE-PTP und VE-Cadherin wird durch sVE-CadherinEC1-5 reduziert. Durch pharmakologische Hem-mung der Phosphataseaktivität von VE-PTP mittels AKB9778 wird der durch sVE-CadherinEC1-5-induzierte Verlust der Endothelbarriere aufgehoben. Dagegen zeigt die direkte Aktivierung von Tie-2 mittels Angiopoetin-1 keinen protektiven Effekt auf die durch sVE-CadherinEC1-5 gestörte Endothelbarriere. Weitere Analysen zeigen eine erhöh-te Expression von GEF-H1 durch sVE-CadherinEC1-5. Diese ist ebenfalls durch AKB9778 hemmbar.
Zusätzlich zu diesen Untersuchungen wurden die Konstrukte EC1-4 und EC3-5 in ver-schiedene Vektoren kloniert, um zu bestimmen, ob die extrazelluläre Domäne 5 von VE-Cadherin die dominante Rolle bei den sVE-Cadherin-vermittelten Effekten spielt.
Zusammenfassend zeigen diese Untersuchungen zum ersten Mal, dass sVE-CadherinEC1-5 unabhängig von proinflammatorischen Auslösern über die Aktivierung des VE-PTP/RhoA-Signalweges den Zusammenbruch der Endothelbarriere mitversursacht. Dies stellt einen neuen pathophysiologischer Mechanismus dar, der zum Gesamtverständnis der entzündungsinduzierten Barriereveränderungen des Endothels beiträgt.
Bei der Atherosklerose handelt es sich um eine chronische inflammatorische Erkrankung, die sich an der arteriellen Gefäßinnenwand abspielt. Ihre Haupt-Manifestationsformen Schlaganfall und Herzinfarkt zählen zu den häufigsten Todesursachen weltweit. Eine chronische Endothelbelastung und -funktionsstörung, beeinflusst durch Risikofaktoren wie Diabetes, arterieller Bluthochdruck, Rauchen und Entzündungszustände, führen zur Permeabilitätserhöhung des Endothels, zur Zelleinwanderung, subendothelialen Lipidanreicherung, Migration glatter Muskelzellen und der Ausbildung atherosklerotischer Läsionen. Es kommt zu Aktivierung des Immunsystems und fortschreitender Entzündungsreaktion, schließlich zur Ausbildung eines nekrotischen Kerns und zunehmender Vulnerabilität des Plaques.
Epigenetische Veränderungen betreffen klassischerweise das Chromatingerüst. Durch DNA-Methylierung und -Demethylierung sowie verschiedene Modifikationen der Histon-Proteine kann die DNA in ihrer Zugänglichkeit verändert werden. So kann die Transkription eines bestimmten Genes direkt und potenziell längerfristig beeinflusst werden, ohne dass Alterationen der DNA-Basenfolge selbst stattfinden. Das Enzym SET7 nimmt hierbei eine Sonderrolle ein, da es neben einer Methylierung von Histon 3 auch verschiedene zelluläre Zielstrukturen posttranslational direkt methylieren kann.
Epigenetische Veränderungen im Kontext der Atherosklerose sind bereits vereinzelt beschrieben. Auch sind sie relevant in der Reaktion auf Umwelteinflüsse und bei inflammatorischen Vorgängen. Der Frage, ob epigenetische Mechanismen im atherosklerotischen Geschehen eine Rolle spielen, sollte in dieser Arbeit nachgegangen werden. Dazu wurde in Zellkulturversuchen für Makrophagen und glatte Muskelzellen geprüft, ob die einzelnen pro-atherosklerotischen Stimuli oxLDL, IL-1β, TNFα und LPS bereits zu relevanten Veränderungen epigenetischer Enzyme führen. Dies erfolgte über Vergleich der entsprechenden mRNA mittels qPCR. Zur Untersuchung der genaueren Dynamik wurde für die Enzyme SET7 und DNMT1 der zeitliche Ablauf dieser Reaktion auf TNFα-Stimulation in Makrophagen genauer betrachtet. Unter gleichen Versuchsbedingungen wurde außerdem die Änderung der mRNA-Expression einiger Matrixmetalloproteasen, TIMP-Enzyme, Zytokine und Transkriptionsfaktoren analysiert,um zukünftig kausale Zusammenhänge weiter aufdecken zu können. Auch die Frage nach Veränderungen epigenetischer Enzyme in der Ldlr-/--Maus nach fettreicher Diät im Vergleich zu Ldlr-/--Mäusen ohne Diät sollte hier beantwortet werden. Dazu wurde die mRNA der Zellsuspensionen aus Milz, Aortenwurzel und gesamter Aorta der Tiere mithilfe der qPCR verglichen. Schließlich sollte ein effizienter Weg für einen individuellen und flexiblen SET7 knock-out etabliert werden, um weitere Studien dieses Enzyms zu ermöglichen. Hierzu wurde die Methode des CRISPR/Cas9 Systems gewählt und abschließend die Funktionalität des Systems überprüft.
Humans spontaneously blink several times a minute. These blinks are strongly modulated during various cognitive task. However, the precise function of blinking and the reason for their modulation has not been fully understood. In the present work, I investigated the function of spontaneous blinks through various perceptual and cognitive tasks. Previous research has revealed that blinks rates decrease during some tasks but increase during others. When trying to understand these seemingly contradictory results, I observed that blink reduction occurs when one engages with an external input. For instance, a decrease has been observed due to the onset of a stimulus, sensory input processing and attention towards sensory input. However, for activities that do not involve such an engagement, e.g. imagination, daydreaming or creativity, the blink rate has been shown to increase. To follow up on the proposed hypothesis, I distinguished tasks that involve the processing of an external stimulus and tasks that involve disengagement.
In the first part of the project, I explored blinking during stimulus engagement. If the probability of blinking is low when engaging with the stimulus, then one should find a reduction in blinks specifically during the time period of processing but not during sensory input per se. To this end, in study 1, I tested the influence of task-relevant information duration on blink timing and additionally manipulated the overall sensory input using a visual and an auditory temporal simultaneity judgement task. The results showed that blinks were suppressed longer for longer periods of relevant information or in other words, blinks occurred at the end of relevant information processing for both the visual and the auditory modality. Since relevance is mediated through top-down processes, I argue that the reduction in blinks is a top-down driven suppression. In studies 2 and 3, I again investigated stimulus processing, but in this case, processing was triggered internally and not based on specific changes in the external input. To this end, I used bistable stimuli, in which the actual physical stimulus remains constant but their perception switches between different interpretations. Studies on the involvement of attention in such bistable perceptual changes indicate that the sensory input is reprocessed before the perceptual switch. The results revealed a reduction in eye blink rates before the report of perceptual switches. Importantly, I was able to decipher that the decrease was not caused by the perceptual switch or the behavioral response but likely started before the internal switch. Additionally, periods between a blink and a switch were longer than interblink intervals, indicating that blinks were followed by a period of stable percept. To conclude, the first part of the project revealed that there is a top-down driven blink suppression during the processing of an external stimulus.
In the second part of the project, I extended the idea of blinks marking the disengagement from external processing and tested if blinking is associated with better performance during internally directed processes. Specifically, I investigated divergent thinking, an aspect of creativity, and the link between performance and blink rates as well as the effect of motor restriction. While I could show that motor restriction was the main factor influencing divergent thinking, the relationship between eye blink rates and creative output also depended on restriction. Results showed that higher blink rates were associated with better performance during free movement, but only between subjects. In other words, subjects who had overall higher blink rates scored better in the task, but when they were allowed to sit or walk freely. Within a single subject, trial with higher blink rates were not associated with better performance. Therefore, possibly, people who are able to disengage easily, as indicated by an overall high blink rate, perform better in divergent thinking tasks. However, the link between blink rate and internal tasks is not clear at this point. Indeed, a more complex measurement of blink behavior might be necessary to understand the relationship.
In the final part of the project, I aimed to further understand the function of blinks through their neural correlates. I extracted the blink-related neural activity in the primary visual cortex (V1) of existing recordings of three rhesus monkeys during different sensory processing states. I analyzed spike related multi-unit responses, frequency dependent power changes, local field potentials and laminar distribution of activity while the animal watched a movie compared to when it was shown a blank screen. The results showed a difference in blink-related neural activity dependent on the processing state. This difference suggests a state dependent function of blinks.
Taken altogether, the work presented in this thesis suggests that eye blinks have an important function during cognitive and perceptual processes. Blinks seem to facilitate a disengagement from the external world and are therefore suppressed during intended processing of external stimuli.
Ubiquitylation is a protein post translational modification, in which ubiquitin is covalently attached to target protein substrates resulting in diverse cellular outcomes. Besides ubiquitin, various ubiquitin-like proteins including FAT10 exist, which are also conjugated to target proteins. The underlying modification mechanisms are conserved. In the initial step, ubiquitin or a ubiquitin-like protein is thioester-linked to a catalytic cysteine in the E1activating enzyme in an ATP-dependent manner. The respective protein modifier is then transferred to an E2 conjugating enzyme in a transthioesterification reaction. Finally, an E3 ubiquitin ligase E3 catalyzes the covalent attachment of the protein modifier to a substrate. In the case of ubiquitin, multiple ubiquitin molecules can be attached to a substrate in the form of either linear or branched polyubiquitin chains but also as single ubiquitin modifications. Depending on the nature of the ubiquitin chain, the substrates are destined to various cellular processes such as their targeted destruction by the proteasome but also non-degradative outcomes may occur.
As stated above FAT10 is a ubiquitin-like protein modifier which typically targets proteins for proteasomal degradation. It consists of two ubiquitin-like domains and is mainly expressed in cells of the human immune system. The reported involvement of FAT10 modifications in cancers and other diseases has caught the attention of the scientific community as an inhibition of the FAT10ylation process may provide avenues for novel therapeutic approaches. UBA6 is the E1 activating enzyme that resides at the apex of the FAT10 proteasomal degradation pathway. UBA6 not only recognizes FAT10 but can also activate ubiquitin as efficiently as the ubiquitin specific E1 UBA1. The dual specificity of UBA6 may complicate the inhibition FAT10ylation since targeting the active site of UBA6 will also inhibit the UBA6-catalyzed ubiquitin activation. Therefore, it is important to understand the underlying principles for the dual specificity of UBA6 prior to the development of compounds interfering with FAT10ylation.
In this thesis important novel insights into the structure and function of UBA6 were derived by X-ray crystallography and biochemical methods. The first crystal structure of UBA6 reveals the multidomain architecture of this enzyme in atomic detail. The enzyme is composed of a rigid core including its active and inactive adenylation domains as well as a 4 helix bundle. Overall, the molecule adopts a “Y” shape architecture with the core at the base and the first and second catalytic half domains forming one arm of the “Y” and the ubiquitin fold domain constituting the other arm. While UBA6 shares the same domain architecture as UBA1, substantial differences were revealed by the crystal structure. In particular, the first catalytic half domain undergoes a significant shift to a position more distal from the core. This rigid body movement is assumed to generate room to accommodate the second ubiquitin-like domain of FAT10. Differences are also observed in a hydrophobic platform between the core and the first catalytic half domain and the adenylation active site in the core, which together from the binding sites for ubiquitin and FAT10. Site directed mutagenesis of key residues in these areas altered the UBA6-catalyzed activation of ubiquitin and FAT10. UBA6 variants were generated with the goal of trying to block the activation of FAT10 while still maintaining that of ubiquitin activation, in order to fully explain the dual specificity of UBA6. However, none of these mutations could block the activation of FAT10, while some of these UBA6 variants blocked ubiquitin activation. Preliminary inhibition assays with a group of E1 inhibitors belonging to the adenosyl sulfamate family demonstrated potent inhibition of FAT10ylation for two compounds. The dual specificity of UBA6 hence needs to be further examined by biochemical and structural methods. In particular, the structure of a complex between UBA6 and ubiquitin or FAT10 would provide key insights for further biochemical studies, ultimately allowing the targeted inhibition of the FAT10ylation machinery.
Sepsis ist eine dysregulierte Reaktion des Organismus auf eine Infektion. Bei Sepsis werden oft Blutungs- und Thromboseereignisse beobachtet, welche in einer Disseminierten Intravasalen Gerinnung (DIG) gipfeln können. Thrombozyten sind die Schlüsselzellen von Thrombose und Hämostase. Bei Sepsis und DIG kommt es häufig zu einem Abfall der Thrombozytenzahl, doch Blutungs- und Thromboseereignisse können unabhängig von der Thrombozytenzahl auftreten, was zusätzlich eine Veränderung der Thrombozytenfunktion nahelegt.
In dieser Arbeit wurde deshalb die Thrombozytenfunktion bei 15 Patienten mit Sepsis zu drei Zeitpunkten im Krankheitsverlauf untersucht. Es konnte bei unauffälliger Rezeptorexpression keine Voraktivierung der Thrombozyten mittels Durchflusszytometrie festgestellt werden. Jedoch war die Aktivierung nach Stimulation mit multiplen Agonisten signifikant reduziert. Besonders ausgeprägt war die Hyporeaktivität bei Stimulation des Kollagen-Rezeptors GPVI mit dem Agonisten CRP-XL. Es wurde gezeigt, dass nach GPVI-Stimulation eine reduzierte Phosphorylierung der nachgeschalteten Proteine Syk und LAT im Vergleich zum Gesundspender induziert wird. In Kreuzinkubationsexperimenten hatte die (Co )Inkubation von Thrombozyten in Plasma von Sepsispatienten oder mit Bakterienisolaten aus Sepsis-Blutkulturen keinen Effekt auf die Thrombozytenreaktivität. Allerdings konnte durch Sepsis-Vollblut eine signifikante GPVI-Hyporeaktivität in Thrombozyten von gesunden Probanden induziert werden, was einen zellulären Mediator als Ursache des Defekts nahelegt. In dieser Arbeit wurde gezeigt, dass insbesondere die GPVI-Signalkaskade bei Sepsis massiv beeinträchtigt ist. Der Immunorezeptor GPVI ist ein vielversprechendes Zielmolekül, um die Pathogenese der Sepsis, des Capillary Leak und die immunregulatorische Rolle von Thrombozyten besser zu verstehen. Die GPVI-Hyporeaktivität könnte als zukünftiger Biomarker für die Sepsis-Frühdiagnose genutzt werden.
This thesis aimed at searching for new effective agents against Multidrug-Resistant Enterobacteriaceae. This is necessitated by the urgent need for new and innovative antibacterial agents addressing the critical priority pathogens prescribed by the World Health Organization (WHO). Among the available means for antibiotics discovery and development, nature has long remained a proven, innovative, and highly reliable gateway to successful antibacterial agents. Nevertheless, numerous challenges surrounding this valuable source of antibiotics among other drugs are limiting the complete realization of its potential. These include the availability of good quality data on the highly potential natural sources, limitations in methods to prepare and screen crude extracts, bottlenecks in reproducing biological potentials observed in natural sources, as well as hurdles in isolation, purification, and characterization of natural compounds with diverse structural complexities.
Through an extensive review of the literature, it was possible to prepare libraries of plant species and phytochemicals with reported high potentials against Escherichia coli and Klebsiella pneumnoniae. The libraries were profiled to highlight the existing patterns and relationships between the reported antibacterial activities and studied plants’ families and parts, the type of the extracting solvent, as well as phytochemicals’ classes, drug-likeness and selected parameters for enhanced accumulation within the Gram-negative bacteria. In addition, motivations, objectives, the role of traditional practices and other crucial experimental aspects in the screening of plant extracts for antibacterial activities were identified and discussed.
Based on the implemented strict inclusion criteria, the created libraries grant speedy access to well-evaluated plant species and phytochemicals with potential antibacterial activities. This way, further studies in yet unexplored directions can be pursued from the indicated or related species and compounds. Moreover, the availability of compound libraries focusing on related bacterial species serves a great role in the ongoing efforts to develop the rules of antibiotics penetrability and accumulation, particularly among Gram-negative bacteria. Here, in addition to hunting for potential scaffolds from such libraries, detailed evaluations of large pool compounds with related antibacterial potential can grant a better understanding of structural features crucial for their penetration and accumulation. Based on the scarcity of compounds with broad structural diversity and activity against Gram-negative bacteria, the creation and updating of such libraries remain a laborious but important undertaking.
A Pressurized Microwave Assisted Extraction (PMAE) method over a short duration and low-temperature conditions was developed and compared to the conventional cold maceration over a prolonged duration. This method aimed at addressing the key challenges associated with conventional extraction methods which require long extraction durations, and use more energy and solvents, in addition to larger quantities of plant materials. Furthermore, the method was intended to replace the common use of high temperatures in most of the current MAE applications. Interestingly, the yields of 16 of 18 plant samples under PMAE over 30 minutes were found to be within 91–139% of those obtained from the 24h extraction by maceration. Additionally, different levels of selectivity were observed upon an analytical comparison of the extracts obtained from the two methods. Although each method indicated selective extraction of higher quantities or additional types of certain phytochemicals, a slightly larger number of additional compounds were observed under maceration. The use of this method allows efficient extraction of a large number of samples while sparing heat-sensitive compounds and minimizing chances for cross-reactions between phytochemicals.
Moreover, findings from another investigation highlighted the low likelihood of reproducing antibacterial activities previously reported among various plant species, identified the key drivers of poor reproducibility, and proposed possible measures to mitigate the challenge. The majority of extracts showed no activities up to the highest tested concentration of 1024 µg/mL. In the case of identical plant species, some activities were observed only in 15% of the extracts, in which the Minimum Inhibitory Concentrations (MICs) were 4 – 16-fold higher than those in previous reports. Evaluation of related plant species indicated better outcomes, whereby about 18% of the extracts showed activities in a range of 128–512 μg/mL, some of the activities being superior to those previously reported in related species.
Furthermore, solubilizing plant crude extracts during the preparation of test solutions for Antibacterial Susceptibility Testing (AST) assays was outlined as a key challenge. In trying to address this challenge, some studies have used bacteria-toxic solvents or generally unacceptable concentrations of common solubilizing agents. Both approaches are liable to give false positive results. In line with this challenge, this study has underscored the suitability of acetone in the solubilization of crude plant extracts. Using acetone, better solubility profiles of crude plant extracts were observed compared to dimethyl sulfoxide (DMSO) at up to 10 %v/v. Based on lacking toxicity against many bacteria species at up to 25 %v/v, its use in the solubilization of poorly water-soluble extracts, particularly those from less polar solvents is advocated.
In a subsequent study, four galloylglucoses were isolated from the leaves of Paeonia officinalis L., whereby the isolation of three of them from this source was reported for the first time. The isolation and characterization of these compounds were driven by the crucial need to continually fill the pre-clinical antibiotics pipeline using all available means. Application of the bioautography-guided isolation and a matrix of extractive, chromatographic, spectroscopic, and spectrometric techniques enabled the isolation of the compounds at high purity levels and the ascertainment of their chemical structures.
Further, the compounds exhibited the Minimum Inhibitory Concentrations (MIC) in a range of 2–256 µg/mL against Multidrug-Resistant (MDR) strains of E. coli and K. pneumonia exhibiting diverse MDR phenotypes. In that, the antibacterial activities of three of the isolated compounds were reported for the first time. The observed in vitro activities of the compounds resonated with their in vivo potentials as determined using the Galleria mellonella larvae model. Additionally, the susceptibility of the MDR bacteria to the galloylglucoses was noted to vary depending on the nature of the resistance enzymes expressed by the MDR bacteria. In that, the bacteria expressing enzymes with higher content of aromatic amino acids and zero or positive net charges were generally more susceptible. Following these findings, a plausible hypothesis for the observed patterns was put forward.
The generally challenging pharmacokinetic properties of galloylglucoses limit their further development into therapeutic agents. However, the compounds can replace or reduce the use of antibiotics in livestock keeping as well as in the treatment of septic wounds and topical or oral cavity infections, among other potential uses.
Using nature-inspired approaches, a series of glucovanillin derivatives were prepared following feasible synthetic pathways which in most cases ensured good yields and high purity levels. Some of the prepared compounds showed MIC values in a range of 128 – 512 μg/mL against susceptible and MDR strains of Klebsiella pneumoniae, Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Enterococcus faecium (VRE). These findings emphasize the previously reported essence of small molecular size, the presence of protonatable amino groups and halogen atoms, as well as an amphiphilic character, as crucial features for potential antibacterial agents.
Due to the experienced limited success in the search for new antibacterial agents using purely synthetic means, pursuing semi-synthetic approaches as employed in this study are highly encouraged. This way, it is possible to explore broader chemical spaces around natural scaffolds while addressing their inherent limitations such as solubility, toxicity, and poor pharmacokinetic profiles.
Strumpellin is a member of the highly conserved pentameric WASH complex, which stimulates the Arp2/3 complex on endosomes and induces the formation of a branched actin network. The WASH complex is involved in the formation and stabilisation of endosomal retrieval subdomains and transport carriers, into which selected proteins are packaged and subsequently transported to their respective cellular destination, e.g. the plasma membrane. Up until now, the role of Strumpellin in platelet function and endosomal trafficking has not been researched. In order to examine its role, a conditional knockout mouse line was generated, which specifically lacked Strumpellin in megakaryocytes and platelets.
Conditional knockout of Strumpellin resulted in only a mild platelet phenotype. Loss of Strumpellin led to a decreased abundance of the αIIbβ3 integrin in platelets, including a reduced αIIbβ3 surface expression by approximately 20% and an impaired αIIbβ3 activation after platelet activation. The reduced surface expression of αIIbβ3 was also detected in megakaryocytes. The expression of other platelet surface glycoproteins was not affected. Platelet count, size and morphology remained unaltered. The reduction of αIIbβ3 expression in platelets resulted in a reduced fibrinogen binding capacity after platelet activation. However, fibrinogen uptake under resting conditions, although slightly delayed, as well as overall fibrinogen content in Strumpellin-deficient platelets were comparable to controls. Most notably, reduced αIIbβ3 expression did not lead to any platelet spreading and aggregation defects in vitro. Furthermore, reduced WASH1 protein levels were detected in the absence of Strumpellin.
In conclusion, loss of Strumpellin does not impair platelet function, at least not in vitro. However, the data demonstrates that Strumpellin plays a role in selectively regulating αIIbβ3 surface expression. As a member of the WASH complex, Strumpellin may regulate αIIbβ3 recycling back to the platelet surface. Furthermore, residual WASH complex subunits may still assemble and partially function in the absence of Strumpellin, which could explain the only 20% decrease in αIIbβ3 surface expression. Nonetheless, the exact mechanism still remains unclear.
Fabry disease (FD), an X-linked lysosomal storage disorder, is caused by variants in the gene α-galactosidase A (GLA). As a consequence, the encoded homonymous enzyme GLA is not produced in sufficient amount or does not function properly. Subsequently, globotriaosylceradmide (Gb3), the target substrate of GLA, starts accumulating in several cell types, especially neurons and endothelial cells. FD patients suffer from multiorgan symptoms including cardiomyopathy, nephropathy, stroke, and acral burning pain. It is suggested that the impact of pathological Gb3 accumulation, inflammatory and hypoxic processes, and vasculopathy are contributing to the specific FD pain phenotype. Thus, we investigated the role of inflammation, hypoxia, and vasculopathy on molecular level in dorsal root ganglia (DRG) of the GLA knockout (KO) mouse model. Further, we investigated pain-like characteristics of GLA KO mice at baseline (BS), after capsaicin administration, and after repeated enzyme replacement therapy (ERT) administration for a period of 1.5 years. Acquired data showed disturbances in immune response markers represented by downregulated inflammation-associated genes and lower numbers of CD206+ macrophages in DRG of GLA KO mice. Hypoxic mechanisms were active in DRG of GLA KO mice reflected by increased gene expression of hypoxia- and DNA damage-associated targets, higher numbers of hypoxia-inducible factor 1α-positive (HIF1α+) and carbonic anhydrase 9-positive (CA9+) neurons in DRG of GLA KO mice, and DRG neuronal HIF1α cytosolic-nuclear translocation in GLA KO mice. Vascularization in DRG of GLA KO mice was reduced including lower numbers of blood vessel branches and reduced total blood vessel length. Pain-like behavior of the GLA KO mouse model revealed no mechanical hypersensitivity at BS but age-dependent heat hyposensitivity, which developed also age-matched wild type (WT) mice. Capsaicin administration under isoflurane anesthesia did not elicit the development of nocifensive behavior in GLA KO mice after mechanical or heat stimulation. Repeated ERT administration did not show a clear effect in GLA KO mice in terms of restored heat hyposensitivity to BS paw withdrawal latencies. In summary, we demonstrated the impact of disturbed immune response markers, active hypoxic mechanisms, and reduced vascularization on molecular FD pathophysiology.